Contentious legality in decentralized governance: The rise and decline of cannabis social clubs in Spain.
A comprehensive policy analysis reveals how Spanish cannabis social clubs legal framework exploited legal ambiguities to create community-based alternatives to illicit markets. The study demonstrates how grassroots activism and strategic legal…
What the DOJ Cannabis Order Means for Patients and Clinicians
The medical cannabis Schedule III order is a major federal policy change, but it is not the same as new clinical proof. This Evidence Watch explains what the DOJ action may mean for research access, patient care, and regulated medical cannabis programs.…
Cannabis Rescheduling Is Not the Story People Think It Is
The cannabis rescheduling clinical impact is being widely misunderstood. While federal policy shifts from Schedule I to Schedule III signal progress, they do not define how cannabis should be used in medical care. This analysis clarifies what changes,…
Sick American Basketball Player Jailed in Indonesia Over Cannabis Gummies
International cannabis legal risks pose serious challenges for medical travelers. This case of a sick American basketball player jailed in Indonesia over cannabis gummies highlights these dangers. Patients must understand legal risks before traveling…
Medical Cannabis Authorization Linked to Modestly Higher Heart Failure Risk in Large Ontario Study
This Ontario cohort study examines medical cannabis cardiovascular safety, finding a modestly higher heart failure risk among authorized patients. The hazard ratio was 1.15, indicating a 15% increased risk for heart failure-related events. These findings…
Falkville Man Arrested with 6 Pounds of Marijuana and Over 1000 THC Vapes
Unregulated cannabis vape safety is a growing concern as large seizures of illegal THC vape cartridges highlight risks. These products often lack quality control and may contain harmful additives. Understanding unregulated cannabis vape safety is…
Canadian Cannabis Legalization Linked to Tens of Thousands of Estimated Annual Deaths—But the Numbers Require Careful Scrutiny
Cannabis-associated health risks contribute to an estimated 28,000 to 30,000 premature deaths annually in Canada. These figures derive from population-attributable fraction modelling rather than direct causal attribution. Understanding…
High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
High-potency cannabis psychiatric risks are increasingly relevant as these products are marketed for mental health conditions despite limited evidence. Clinicians must understand these risks to guide patients effectively. This article highlights the…
JISTV | Official Launch of Medicinal Cannabis Special Permit Programmes – YouTube
The 2026 launch of medicinal cannabis special permit programmes marks a critical shift in patient access and regulatory frameworks. These programmes influence physician education and prescription protocols. Understanding these changes is essential for…
Cannabis Europa Returns to London with Patient Issues on the Agenda
Cannabis patient advocacy initiatives are gaining prominence at Cannabis Europa in London. These initiatives emphasize patient-centered approaches to cannabis medicine development. They aim to improve clinical access and address real-world challenges in…